These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 39212993)

  • 1. Racial and Ethnic Disparities in Take-Home Methadone Use for Medicare Beneficiaries With Opioid Use Disorder.
    Choi S; Zhang Y; Unruh MA; McGinty EE; Jung HY
    JAMA Netw Open; 2024 Aug; 7(8):e2431620. PubMed ID: 39212993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in Opioid Agonist Dosing in Clinical Trials by Race and Ethnicity.
    Ross RK; Inose S; Shulman M; Nunes EV; Zalla LC; Burlew AK; Rudolph KE
    JAMA Netw Open; 2024 Oct; 7(10):e2436612. PubMed ID: 39365581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Racial and Ethnic Disparities in the Use of Medication to Treat Opioid Use Disorder Among Pregnant Women in Massachusetts.
    Schiff DM; Nielsen T; Hoeppner BB; Terplan M; Hansen H; Bernson D; Diop H; Bharel M; Krans EE; Selk S; Kelly JF; Wilens TE; Taveras EM
    JAMA Netw Open; 2020 May; 3(5):e205734. PubMed ID: 32453384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicare Payment for Opioid Treatment Programs.
    Nakamoto CH; Huskamp HA; Donohue JM; Barnett ML; Gordon AJ; Mehrotra A
    JAMA Health Forum; 2024 Jul; 5(7):e241907. PubMed ID: 39028654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes In County-Level Access To Medications For Opioid Use Disorder After Medicare Coverage Of Methadone Treatment Began.
    Harris SJ; Yarbrough CR; Abraham AJ
    Health Aff (Millwood); 2023 Jul; 42(7):991-996. PubMed ID: 37406230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes.
    Taylor EA; Cantor JH; Bradford AC; Simon K; Stein BD
    JAMA Netw Open; 2023 May; 6(5):e2314328. PubMed ID: 37204793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual mental health diagnoses predict the receipt of medication-assisted opioid treatment: Associations moderated by state Medicaid expansion status, race/ethnicity and gender, and year.
    Pro G; Utter J; Haberstroh S; Baldwin JA
    Drug Alcohol Depend; 2020 Apr; 209():107952. PubMed ID: 32172130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial/ethnic disparities in timely receipt of buprenorphine among Medicare disability beneficiaries.
    Miles J; Treitler P; Hermida R; Nyaku AN; Simon K; Gupta S; Crystal S; Samples H
    Drug Alcohol Depend; 2023 Nov; 252():110963. PubMed ID: 37748421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction of Medicare coverage in opioid treatment programs: Findings from the first three years.
    Abraham AJ; Harris SJ; Yarbrough CR
    J Subst Use Addict Treat; 2024 Mar; 158():209247. PubMed ID: 38072386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction effects in the association between methadone maintenance therapy and experiences of racial discrimination in U.S. healthcare settings.
    Pro G; Zaller N
    PLoS One; 2020; 15(2):e0228755. PubMed ID: 32027723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Relapse and Higher Costs Among Medicaid Members with Opioid Dependence or Abuse: Opioid Agonists, Comorbidities, and Treatment History.
    Clark RE; Baxter JD; Aweh G; O'Connell E; Fisher WH; Barton BA
    J Subst Abuse Treat; 2015 Oct; 57():75-80. PubMed ID: 25997674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial and Ethnic Disparities in Opioid Prescribing on Hospital Discharge Among Older Adults: A National Retrospective Cohort Study.
    Kasanagottu K; Anderson TS; Trivedi S; Ngo LH; Schnipper JL; McCarthy EP; Herzig SJ
    J Gen Intern Med; 2024 Jun; 39(8):1444-1451. PubMed ID: 38424348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
    Jones CM; Shoff C; Hodges K; Blanco C; Losby JL; Ling SM; Compton WM
    JAMA Psychiatry; 2022 Oct; 79(10):981-992. PubMed ID: 36044198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A population-based examination of trends and disparities in medication treatment for opioid use disorders among Medicaid enrollees.
    Stein BD; Dick AW; Sorbero M; Gordon AJ; Burns RM; Leslie DL; Pacula RL
    Subst Abus; 2018; 39(4):419-425. PubMed ID: 29932847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder.
    Wakeman SE; Larochelle MR; Ameli O; Chaisson CE; McPheeters JT; Crown WH; Azocar F; Sanghavi DM
    JAMA Netw Open; 2020 Feb; 3(2):e1920622. PubMed ID: 32022884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender disparities in opioid treatment progress in methadone versus counseling.
    Guerrero E; Amaro H; Kong Y; Khachikian T; Marsh JC
    Subst Abuse Treat Prev Policy; 2021 Jun; 16(1):52. PubMed ID: 34162420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial Inequality in Receipt of Medications for Opioid Use Disorder.
    Barnett ML; Meara E; Lewinson T; Hardy B; Chyn D; Onsando M; Huskamp HA; Mehrotra A; Morden NE
    N Engl J Med; 2023 May; 388(19):1779-1789. PubMed ID: 37163624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial and Ethnic Inequities in Buprenorphine and Methadone Utilization Among Reproductive-Age Women with Opioid Use Disorder: an Analysis of Multi-state Medicaid Claims in the USA.
    Xu KY; Schiff DM; Jones HE; Martin CE; Kelly JC; Bierut LJ; Carter EB; Grucza RA
    J Gen Intern Med; 2023 Dec; 38(16):3499-3508. PubMed ID: 37436568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the delivery of medications for opioid use disorder during hospitalization by racial categories: A retrospective cohort analysis.
    Priest KC; King CA; Englander H; Lovejoy TI; McCarty D
    Subst Abus; 2022; 43(1):1251-1259. PubMed ID: 35670778
    [No Abstract]   [Full Text] [Related]  

  • 20. Racial And Ethnic Disparities In Buprenorphine Receipt Among Medicare Beneficiaries, 2015-19.
    Miles J; Treitler P; Lloyd J; Samples H; Mahone A; Hermida R; Gupta S; Duncan A; Baaklini V; Simon KI; Crystal S
    Health Aff (Millwood); 2023 Oct; 42(10):1431-1438. PubMed ID: 37782874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.